These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27918462)

  • 1. Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo.
    Cartland SP; Genner SW; Zahoor A; Kavurma MM
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27918462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor and vascular endothelial growth factor play a critical role in endotheliogenesis from human adipose-derived stem cells.
    Khan S; Villalobos MA; Choron RL; Chang S; Brown SA; Carpenter JP; Tulenko TN; Zhang P
    J Vasc Surg; 2017 May; 65(5):1483-1492. PubMed ID: 27514438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms.
    Di Bartolo BA; Cartland SP; Prado-Lourenco L; Griffith TS; Gentile C; Ravindran J; Azahri NS; Thai T; Yeung AW; Thomas SR; Kavurma MM
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26572549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
    Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
    J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.
    Kaur G; Belotti D; Burger AM; Fisher-Nielson K; Borsotti P; Riccardi E; Thillainathan J; Hollingshead M; Sausville EA; Giavazzi R
    Clin Cancer Res; 2004 Jul; 10(14):4813-21. PubMed ID: 15269157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo.
    Kolmakova A; Rajesh M; Zang D; Pili R; Chatterjee S
    Glycoconj J; 2009 Jul; 26(5):547-58. PubMed ID: 19219548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo.
    Bai Y; Leng Y; Yin G; Pu X; Huang Z; Liao X; Chen X; Yao Y
    Cell Tissue Res; 2014 Apr; 356(1):109-21. PubMed ID: 24442492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
    Bai Y; Bai L; Zhou J; Chen H; Zhang L
    Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
    Mader JS; Smyth D; Marshall J; Hoskin DW
    Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF-2-mediated FGFR1 signaling in human microvascular endothelial cells is activated by vaccarin to promote angiogenesis.
    Sun HJ; Cai WW; Gong LL; Wang X; Zhu XX; Wan MY; Wang PY; Qiu LY
    Biomed Pharmacother; 2017 Nov; 95():144-152. PubMed ID: 28841454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of basic fibroblast growth factor and vascular endothelial growth factor on the proliferation, migration and adhesion of human periodontal ligament stem cells in vitro].
    Zhang R; Zhang M; Li CH; Wang PC; Chen F; Wang QT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 May; 48(5):278-84. PubMed ID: 24004623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis.
    Claffey KP; Abrams K; Shih SC; Brown LF; Mullen A; Keough M
    Lab Invest; 2001 Jan; 81(1):61-75. PubMed ID: 11204275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sponge/Matrigel angiogenesis assay.
    Akhtar N; Dickerson EB; Auerbach R
    Angiogenesis; 2002; 5(1-2):75-80. PubMed ID: 12549862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo.
    Cho HD; Moon KD; Park KH; Lee YS; Seo KI
    Food Chem Toxicol; 2018 Nov; 121():612-621. PubMed ID: 30236598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo.
    Tammali R; Reddy AB; Srivastava SK; Ramana KV
    Angiogenesis; 2011 May; 14(2):209-21. PubMed ID: 21409599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cheiradone: a vascular endothelial cell growth factor receptor antagonist.
    Hussain S; Slevin M; Mesaik MA; Choudhary MI; Elosta AH; Matou S; Ahmed N; West D; Gaffney J
    BMC Cell Biol; 2008 Jan; 9():7. PubMed ID: 18230134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.